Evidence map›Paper›PMID 28864779›Full record

ArticleBioscience reports2017

RNAi-mediated

Jie Ma, Xian-Bin Wang, Rui Li, Shu-Hong Xuan, Fang Wang, Xin-Hua Li, Zhi-Ping Zhang, Lu Tan, Lian Li

RetractedOpen access · goldAbstract readRetracted Publication
PubMed Full text at PMC Publisher
In one paragraph

Article in Bioscience reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Jie MaDepartment of Oncology, Jining No. 1 People's Hospital, Jining 272011, P.R. China.
Xian-Bin WangDepartment of Breast and Thyroid Surgery, Jining No. 1 People's Hospital, Jining 272011, P.R. China.
Rui LiDepartment of Oncology, Jining No. 1 People's Hospital, Jining 272011, P.R. China.
Shu-Hong XuanDepartment of Neurology, Jining No. 1 People's Hospital, Jining 272011, P.R. China.
Fang WangDepartment of Oncology, Jining No. 1 People's Hospital, Jining 272011, P.R. China.
Xin-Hua LiDepartment of Internal Medicine, Jining No. 1 People's Hospital, Jining 272011, P.R. China.
Zhi-Ping ZhangDepartment of Breast and Thyroid Surgery, Jining No. 1 People's Hospital, Jining 272011, P.R. China Drzhang_zzp@126.com.
Lu TanDepartment of Oncology, The Second Hospital of Shandong University, Jinan 250033, P.R. China.
Lian LiDepartment of Oncology, The Second Hospital of Shandong University, Jinan 250033, P.R. China.
Jining First People's Hospital · CNSecond Hospital of Shandong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Esophageal cancer (EC) remains an important health problem in China. In the present study, through the use of siRNA, specific gene knockdown of transcription factor 3 gene (

Indexed as

Gene Expression Regulation, NeoplasticGene SilencingApoptosisBasic Helix-Loop-Helix Proteinsbcl-2-Associated X ProteinCaspase 3Cell Line, TumorCell ProliferationEsophagusG1 Phase Cell Cycle CheckpointsHumansProto-Oncogene Proteins c-bcl-2RNA, Small InterferingBasic Helix-Loop-Helix ProteinsBAX protein, humanbcl-2-Associated X ProteinBCL2 protein, humanCASP3 protein, humanCaspase 3Proto-Oncogene Proteins c-bcl-2RNA, Small InterferingTCF3 protein, humanCell cycleEca-109 cellEsophageal cancerProliferationSiRNATranscription factor 3 gene

Identifiers

PMID28864779
PMCPMC5678029
OpenAlexW2753506022

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.